Document:

ex_428502.htm

Exhibit 10.3

 

 

VOTING AND SUPPORT AGREEMENT OF RHODIUM ENTERPRISES, INC. 

 

This Voting and Support Agreement (this “Agreement”), dated as of September 29, 2022, is entered into by and among Rhodium Enterprises, Inc., a Delaware a corporation (the “Company”), each of the Persons signatory to this Agreement (each, a “Stockholder”) and SilverSun Technologies, Inc., a Delaware corporation (“Parent”). Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to them in the Merger Agreement (as defined below).

 

RECITALS

 

WHEREAS, Parent, Rhodium Enterprises Acquisition Corp., a Delaware corporation and direct wholly owned subsidiary of Parent (“Merger Sub I”), Rhodium Enterprises Acquisition LLC, a Delaware limited liability company and direct wholly owned subsidiary of Parent (“Merger Sub II”), and the Company have entered into that certain Agreement and Plan of Merger, dated as of the date of this Agreement (as amended, supplemented, restated or otherwise modified from time to time, the “Merger Agreement”), pursuant to which (and subject to the terms and conditions set forth in the Merger Agreement) (i) Merger Sub I will merge with and into the Company (the “First Merger”) with the Company surviving the First Merger as a wholly owned subsidiary of Parent, (ii) then, the Company will merge with and into Merger Sub II (the “Second Merger”) with Merger Sub II surviving the Second Merger as a wholly owned subsidiary of Parent, (iii) by virtue of the First Merger, holders of Company Common Stock will receive for each share of Company Common Stock (other than Dissenting Shares and Excluded Company Shares) held as of the First Effective Time, the Class A Merger Consideration or Class B Merger Consideration, as applicable, and holders of Merger Sub I Common Stock will receive for each share of Merger Sub I Common Stock held as of the First Effective Time, one validly issued, fully paid and nonassessable share of common stock of the First Surviving Company, and (iv) by virtue of the Second Merger, each share of capital stock of the First Surviving Company shall be cancelled and holders of each limited liability company interest of Merger Sub II will receive for each limited liability company interest of Merger Sub II held immediately prior to the Second Effective Time, one validly issued, fully paid and (to the extent applicable) nonassessable limited liability company interest of the Surviving Company, as applicable;

 

WHEREAS, as of the date of this Agreement, each Stockholder is the record and “beneficial owner” (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated under the Exchange Act, the “Exchange Act”)) of and is entitled to dispose of and vote the number of shares of Company Common Stock set forth on each such Stockholder’s signature page to this Agreement (the “Owned Shares”; the Owned Shares and any additional shares of voting securities of the Company (or any securities convertible into or exercisable or exchangeable for voting securities of the Company) in which each Stockholder acquires record and beneficial ownership after the date of this Agreement, including by purchase, as a result of a stock dividend, stock split, recapitalization, combination, reclassification, exchange or change of such shares, or upon exercise or conversion of any securities, the “Covered Shares”); and

 

WHEREAS, as a condition and inducement to the willingness of Parent to enter into the Merger Agreement, the Company has agreed to obtain this Agreement executed by each of the directors, executive officers and certain stockholders of the Company.

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements contained in this Agreement, and intending to be legally bound, the Company, Parent and each Stockholder, severally and not jointly, agree as follows:

 

 

1.    Agreement to Vote.  Prior to the Expiration Time (as defined below), each Stockholder, in his, her or its capacity as a stockholder of the Company, irrevocably and unconditionally agrees that, at any meeting of the stockholders of the Company (whether annual or special and whether or not an adjourned or postponed meeting, however called and including any adjournment or postponement of such meeting, or in any other circumstance in which the vote, consent or other approval of the stockholders of the Company is sought (each, a “Stockholders Meeting”)), such Stockholder shall, and shall cause any other holder of record of any of the Stockholder’s Covered Shares, to:

 

1

 

 

a.    appear at each Stockholders Meeting or otherwise cause the Stockholder’s Covered Shares to be counted as present at such meeting for the purpose of establishing a quorum;

 

b.    vote, or cause to be voted, at each such Stockholders Meeting, in person or by proxy, or execute and deliver the Written Consent (or cause the Written Consent to be executed and delivered) covering, all of the Stockholder’s Covered Shares owned as of the record date for such Stockholders Meeting in favor of the Transactions, including the Mergers, the adoption of the Merger Agreement and the Ancillary Agreements and any other matters necessary or reasonably requested by the Company for consummation of the Transactions, including the Mergers, and the other transactions and actions contemplated by the Merger Agreement and the Ancillary Agreements, and any proposal to adjourn or postpone any Stockholders Meeting recommended by the Company to the extent permitted or required by Section 5.18 of the Merger Agreement; and

 

c.    vote or cause to be voted at each such Stockholders Meeting, in person or by proxy, or execute and deliver a written consent (or cause a written consent to be executed and delivered) covering, all of the Stockholder’s Covered Shares against any merger, consolidation, business combination, reorganization, recapitalization, liquidation or sale or transfer of any material assets of the Company and any other action that (i) would reasonably be expected to compete with, impede, interfere with, delay, postpone, impair, frustrate, discourage or adversely affect any of the Transactions, including the Mergers or any of the other transactions contemplated by the Merger Agreement, result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the Merger Agreement or inhibit the timely consummation of any other obligation or agreement in the Merger Agreement or this Agreement or (ii) would result in the failure of any condition set forth in Section 6.01, Section 6.02 or Section 6.03 of the Merger Agreement to be satisfied or result in a breach of any covenant, representation or warranty or other obligation or agreement of the Stockholder contained in this Agreement; provided, however, that nothing in this Agreement shall limit or restrict the Stockholder from voting on any matter other than those explicitly set forth in this Section 1(c), in such Stockholder’s sole discretion.

 

The obligations of each Stockholder specified in this Section 1 shall apply whether or not the Transactions, including the Mergers or any other action described above is recommended by the Company Board. For purposes of this Agreement, “Person” shall mean any individual, corporation, partnership, limited partnership, limited liability company, syndicate, person (including a “person” as defined in Section 13(d)(3) of the Exchange Act), trust, association or other entity or government, political subdivision, agency or instrumentality of a government.

 

Until the Expiration Time, each Stockholder irrevocably appoints as its proxy and attorney-in-fact, the Company and any other Person designated in writing by the Company, each of them individually, with full power of substitution and re-substitution, to vote the Covered Shares, or grant consent or approval in respect of the Covered Shares, held by such Stockholder from time to time, regarding the matters referred to in this Section 1 as provided in this Agreement prior to the Expiration Time at any Stockholders Meeting at which any of the matters described in this Section 1 are to be considered; provided, however, that each Stockholder’s grant of the proxy contemplated by this Section 1 shall be effective if, and only if, such Stockholder has not delivered to the Secretary of the Company (or other authorized officer) at least ten (10) Business Days prior to the Stockholders Meeting at which any of the matters described in this Section 1 is to be considered a duly executed irrevocable proxy card validly directing that the Covered Shares held by such Stockholder at such time be voted, or consent be given, in accordance with this Section 1. This proxy is coupled with an interest and is given as an additional inducement of Parent to enter into the Merger Agreement and shall be irrevocable except upon termination of this Agreement, at which time any such proxy shall terminate. Each Stockholder (solely in its capacity as a stockholder of the Company) shall take such further actions or execute such other instruments as may be necessary to effectuate the intent of this proxy. The Company may terminate this proxy with respect to any Stockholder at any time at its sole election by written notice provided to the applicable Stockholder. Each Stockholder affirms that the irrevocable proxy granted in this Section 1 is given in connection with the execution of the Merger Agreement and that such irrevocable proxy is given to secure the performance of the duties of such Stockholder under this Agreement. Each Stockholder further affirms that the irrevocable proxy granted in this Section 1 is coupled with an interest and may under no circumstances be revoked so long as the Stockholder has not delivered an executed irrevocable proxy card validly directing the vote of such Stockholder’s Covered Shares pursuant to the first sentence of this

 

2

 

 

paragraph. Each Stockholder further ratifies and confirms that such irrevocable proxy may lawfully vote, or cause to be voted, all of the Covered Shares in favor of the actions contemplated this Agreement by virtue of being granted such proxy. Without limiting the generality of the foregoing, such irrevocable proxy is executed and intended to be irrevocable in accordance with the provisions of Section 212 of the DGCL. If for any reason the proxy granted herein is not irrevocable, each Stockholder agrees to vote the Covered Shares in accordance with this Section 1.

 

2.    No Inconsistent Agreements.  Each Stockholder covenants and agrees that the Stockholder shall not, at any time prior to the Expiration Time, (i) deposit any or all of the Covered Shares into a voting trust or enter into any voting agreement or voting trust with respect to any of the Stockholder’s Covered Shares, (ii) grant a proxy or power of attorney with respect to any of the Stockholder’s Covered Shares (except as set forth in this Agreement), or (iii) enter into any Contract, agreement or undertaking, or take any other action, that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying, its obligations pursuant to this Agreement, make any representation or warranty of such Stockholder contained in this Agreement untrue or incorrect or in any way restrict, limit or interfere with the performance of such Stockholder’s obligations under this Agreement or the transactions contemplated by this Agreement or by the Merger Agreement.

 

3.    Termination.  This Agreement shall automatically terminate, without any notice or other action by any party, be void ab initio and no party shall have any further obligations or liabilities under this Agreement, upon the earliest of (i) the Effective Time, (ii) the valid termination of the Merger Agreement in accordance with Article VII of the Merger Agreement, (iii) the time this Agreement is terminated upon the mutual written agreement of the Company, Parent, and each Stockholder party to this Agreement, or (iv) the election of the Stockholder in his, her or its sole discretion to terminate this Agreement with respect to such Stockholder only following any material modification or amendment to, as in effect on the date of this Agreement, that alters (other than in a de minimis manner) the Merger Consideration in a manner which is adverse to the holders of Company Common Stock, taken as whole, from a financial point of view, or materially changes the method for determining any exchange ratio provided for with respect to the applicable Company Common Stock in the Merger Agreement (without the Stockholder’s prior written consent) (the earliest such date under clauses (i)-(iv) being referred to in this Agreement as the “Expiration Time”); provided, that the provisions set forth in Sections 10 to 22 of this Agreement shall survive the termination of this Agreement; provided, further, that nothing herein shall relieve any party from Liability for any fraud, intentional misrepresentation or willful and material breach of this Agreement prior to such termination.

 

4.    Representations and Warranties of the Stockholders.  Each Stockholder, severally and not jointly, represents and warrants to Parent as to itself as follows:

 

a.    The Stockholder is the sole and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and has good, valid and marketable title to, its Owned Shares. Except as permitted by this Agreement, the Owned Shares and the certificates representing the Owned Shares, if any, are now, and at all times prior to the Expiration Time will be, free and clear of all Liens other than as created by this Agreement. As of the date of this Agreement, other than the Owned Shares and any other shares of capital stock of the Company that become Covered Shares that the Stockholder acquires record or beneficial ownership after the date of this Agreement that is either permitted pursuant to, or acquired in accordance with, Section 5.01(c)(iii) of the Merger Agreement, the Stockholder does not own beneficially or of record, and does not have any right to acquire, any shares of capital stock of the Company (or any securities convertible into shares of capital stock of the Company).

 

b.    The Stockholder (i) except as provided in this Agreement, has, and will have at all times through the Expiration Time, full and sole voting power, power of disposition and power to issue instructions with respect to the matters set forth in this Agreement, in each case, with respect to all of the Stockholder’s Covered Shares, (ii) has not deposited any or all of the Covered Shares into a voting trust or entered into any voting agreement or voting trust with respect to any of the Stockholder’s Covered Shares, (iii) except as provided in this Agreement, has not granted a proxy or power of attorney with respect to any of the Stockholder’s Covered Shares and (iv) has not entered into any agreement or undertaking that is otherwise inconsistent with, or would interfere with, or prohibit or prevent it from satisfying, its obligations pursuant to this Agreement.

 

c.    The Stockholder (i) if a legal entity, is duly organized, validly existing and, to the extent such concept is applicable, in good standing under the Laws of the jurisdiction of its organization and has all requisite corporate or other power and authority and has taken all corporate or other action necessary in order

 

3

 

 

 to, execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated by this Agreement or (ii) if an individual, has legal competence and capacity to enter into this Agreement and all necessary authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated by this Agreement. This Agreement has been duly executed and delivered by the Stockholder and constitutes a valid and binding agreement of the Stockholder enforceable against the Stockholder in accordance with its terms, in either case, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar Laws of general applicability relating to or affecting creditor’s rights, and to general equitable principles. If the Stockholder is an individual and is married, and any of the Covered Shares constitute community property or spousal approval is otherwise necessary for this Agreement to be legal, binding and enforceable, this Agreement has been duly authorized, executed and delivered by, and constitutes the legal, valid and binding obligation of, the Stockholder’s spouse, enforceable against the Stockholder’s spouse in accordance with its terms.

 

d.    Other than the filings, notices and reports pursuant to, in compliance with or required to be made under the Exchange Act, no filings, notices, reports, consents, registrations, approvals, permits, waivers, expirations of waiting periods or authorizations are required to be obtained by the Stockholder from, or to be given by the Stockholder to, or be made by the Stockholder with, any Governmental Authority in connection with the execution, delivery and performance by the Stockholder of this Agreement, the consummation of the transactions contemplated by this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under this Agreement that relate to the provisions of the Merger Agreement).

 

e.    The execution, delivery and performance of this Agreement by each Stockholder does not, and the consummation of the transactions contemplated by this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under this Agreement that relate to the provisions of the Merger Agreement) will not, constitute or result in (i) if the Stockholder is a legal entity, a breach or violation of, or a default under, the certificate of incorporation, limited liability company agreement or similar organizational or governing documents of the Stockholder, (ii) with or without notice, lapse of time or both, a breach or violation of, a termination (or right of termination) of or a default under, the loss of any benefit under, the creation, modification or acceleration of any obligations under or the creation of a Lien on the Covered Shares pursuant to any Contract binding upon the Stockholder or, assuming (solely with respect to performance of this Agreement and the transactions contemplated by this Agreement), compliance with the matters referred to in Section 4(d), under any applicable Law to which the Stockholder is subject or (iii) any change in the rights or obligations of any party under any Contract legally binding upon the Stockholder, except, in the case of clause (ii) or (iii) directly above, for any such breach, violation, termination, default, creation, loss, acceleration, Lien or change that would not, individually or in the aggregate, reasonably be expected to prevent or materially delay or impair the Stockholder’s ability to perform its obligations under this Agreement or to consummate the transactions contemplated by this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under this Agreement that relate to the provisions of the Merger Agreement).

 

f.    As of the date of this Agreement, there is no Legal Action, proceeding or, to the Stockholder’s knowledge, investigation pending against the Stockholder or, to the knowledge of the Stockholder, threatened against the Stockholder that questions the beneficial or record ownership of the Stockholder’s Owned Shares, the validity of this Agreement or the performance by the Stockholder of its obligations under this Agreement.

 

g.    The Stockholder has received and reviewed a copy of the Merger Agreement. The Stockholder understands and acknowledges that Parent is entering into the Merger Agreement in reliance upon each Stockholder’s execution and delivery of this Agreement and the representations, warranties, covenants and other agreements of the Stockholder contained in this Agreement.

 

5.    Certain Covenants of the Stockholders.  Except in accordance with the terms of this Agreement, each Stockholder covenants and agrees, severally and not jointly, as follows:

 

a.    Each Stockholder agrees not to, directly or indirectly, prior to the Expiration Time, except in connection with the consummation of the Transactions, including the Mergers, (i) sell, transfer, pledge, encumber, assign, hedge, swap, convert or otherwise dispose of (including by merger (including by

 

4

 

 

 conversion into securities or other consideration), by tendering into any tender or exchange offer, by operation of Law or otherwise), either voluntarily or involuntarily (collectively, “Transfer”), offer to Transfer or consent to any Transfer or enter into any Contract, option or other agreement or understanding with respect to the Transfer of any or all of such Stockholder’s Covered Shares, or (ii) take any action or agree or commit to take any action that would make any representation or warranty of such Stockholder contained in this Agreement untrue or incorrect or have the effect of preventing or materially delaying the Stockholder from or in performing its obligations under this Agreement; provided, however, that nothing in this Section 5 shall prohibit a Transfer (A) if the Stockholder is not an individual, to an Affiliate of the Stockholder, (B) occurring by will, testamentary document or intestate succession upon the death of a Stockholder who is an individual or (C) pursuant to community property Laws or divorce decree (each, a “Permitted Transfer”); provided, further, that any Permitted Transfer shall be permitted only if, as a precondition to such Transfer, the transferee also agrees in a writing, reasonably satisfactory in form and substance to the Company, to assume all of the obligations of the Stockholder under, and be bound by all of the terms of, this Agreement in respect of the Covered Shares so Transferred and any Covered Shares subsequently acquired; provided, further, that any Transfer permitted under this Section 5(a) shall not relieve the Stockholder of its obligations under this Agreement. Any Transfer in violation of this Section 5(a) with respect to the Stockholder’s Covered Shares shall be null and void ab initio.

 

b.    Each Stockholder authorizes the Company to maintain a copy of this Agreement at either the executive office or the registered office of the Company.

 

c.    Each Stockholder waives, and agrees not to exercise or assert, if applicable, any appraisal rights, dissenter’s rights or similar rights (whether under Section 262 of the DGCL or other applicable Law) in connection with the Mergers and agrees not to commence or participate in, assist or knowingly encourage, and to take all actions necessary to opt out of, any class in any class action with respect to, any action or claim, derivative or otherwise, against Parent, Merger Sub I, Merger Sub II, the Company or any of their respective Subsidiaries or Affiliates and each of their successors and permitted assigns relating to the negotiation, execution or delivery of this Agreement or the Merger Agreement or the consummation of the Mergers, including any claim (i) challenging the validity of, or seeking to enjoin the operation of, any provision of this Agreement (including any claim seeking to enjoin or delay the closing of the Merger), or (ii) alleging a breach of any fiduciary duty of the Company Board in connection with the Merger Agreement or the transactions contemplated by the Merger Agreement; provided, that nothing in this Section 5(c) shall restrict or prohibit the Stockholder from asserting its right to receive the Merger Consideration in accordance with the Merger Agreement and the DGCL (or other applicable Law).

 

6.    Further Assurances.  From time to time, at Parent’s or the Company’s request and without further consideration, any such Stockholder shall execute and deliver such additional documents and take all such further action as may be reasonably necessary or reasonably requested to effect the actions and consummate the transactions contemplated by this Agreement and the Merger Agreement.

 

7.    Disclosure.  Each Stockholder authorizes the Company and Parent to publish and disclose in any announcement or disclosure to the extent required by Law, rule or regulation by the SEC the Stockholder’s identity and ownership of the Covered Shares and the nature of the Stockholder’s obligations under this Agreement; provided, that prior to any such publication or disclosure the Company and Parent have provided the Stockholder with a reasonable opportunity to review and comment upon such announcement or disclosure, which comments the Company and Parent will consider in good faith.

 

8.    Changes in Capital Stock.  In the event of a stock split, stock dividend or distribution, or any change in the Company’s capital stock by reason of any split-up, reverse stock split, recapitalization, combination, reclassification, exchange of shares or the like, the terms “Owned Shares” and “Covered Shares” shall be deemed to refer to and include such shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which are received in such transaction.

 

9.    Amendment and Modification.  This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or otherwise, except by an instrument in writing signed by each party to this Agreement.

 

10.    Waiver.  Any party to this Agreement may, at any time prior to the Expiration Time, waive any of the terms or conditions of this Agreement, or agree to an amendment or modification to this Agreement in the

 

5

 

 

manner contemplated by Section 9 and by an agreement in writing executed in the same manner (but not necessarily by the same Persons) as this Agreement. Notwithstanding the foregoing, no failure or delay by any party in exercising any right under this Agreement shall operate as a waiver of such right nor shall any single or partial exercise of such right preclude any other or further exercise of any other right under this Agreement.

 

11.    Notices.  All notices and other communications required or otherwise provided pursuant to this Agreement shall be in writing and shall be addressed as follows (or at such other address for a party as shall be specified by like notice):

 

if to a Stockholder, to it at the address and other contact information set forth on such Stockholder’s signature page to this Agreement;

 

if to the Company, to it at:

 

Rhodium Enterprises, Inc.

7546 Pebble Drive, Building 29

Fort Worth, Texas 76118

Attention: Chase Blackmon, Chief Executive Officer; Nick

Cerasuolo, Chief Financial Officer

E-mail: chaseblackmon@rhdm.com; nickcerasuolo@rhdm.com

 

 

with a copy (which shall not constitute notice) to:

 

Kirkland & Ellis LLP

609 Main Street

Houston, TX 77002

Attention: Thomas Laughlin, P.C.; Jack Shirley; Douglas E. Bacon, P.C.;

Matthew R. Pacey, P.C.; Anne Peetz

E-mail: thomas.laughlin@kirkland.com;

jack.shirley@kirkland.com;

doug.bacon@kirkland.com; matt.pacey@kirkland.com;

anne.peetz@kirkland.com

 

 

 

if to Parent, to it at:

 

SilverSun Technologies, Inc.

120 Eagle Rock Avenue

East Hanover, NJ 07936

Attention: Mark Meller, Chief Executive Officer

Telephone: (973) 758-6100

Email: meller@silversuntech.com

 

with a copy (which shall not constitute notice) to:

 

Lucosky Brookman LLP

101 Wood Avenue South, 5th Floor

Woodbridge, NJ 08830

Attention: Joseph Lucosky; Chris Haunschild

Email: jlucosky@lucbro.com; chaunschild@lucbro.com

 

All such notices or communications shall be deemed to have been delivered and received: (i) if delivered in person, on the day of such delivery, (ii) if by electronic mail, on the day on which such electronic mail was sent and duly delivered, (iii) if by certified or registered mail (return receipt requested), postage prepaid, on the third (3rd) Business Day after mailing or (iv) if by reputable overnight delivery service, on the first (1st) Business Day after mailing.

 

6

 

 

12.    No Ownership Interest.  Nothing contained in this Agreement shall be deemed to vest in Parent or the Company any direct or indirect ownership or incidence of ownership of or with respect to the Covered Shares of any Stockholder. All rights, ownership and economic benefits of and relating to the Covered Shares of each Stockholder shall remain vested in and belong to such Stockholder, and the Company shall have no authority to manage, direct, restrict, regulate, govern or administer any of the policies or operations of Company or exercise any power or authority to direct such Stockholder in the voting or disposition of any of the Stockholder’s Covered Shares, except as otherwise provided in this Agreement.

 

13.    Entire Agreement.  This Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under this Agreement that relate to the provisions of the Merger Agreement) and any Ancillary Agreement as to which the Company or Parent, on the one hand, and the Stockholders on the other hand, are parties constitute the entire agreement among the parties relating to the subject matter of this Agreement and supersede any other agreements, whether written or oral, that may have been made or entered into by or among any of the parties to this Agreement or any of their respective Subsidiaries relating to the transactions contemplated by this Agreement.

 

14.    No Third-Party Beneficiaries.  Each Stockholder agrees that its representations, warranties and covenants set forth in this Agreement are solely for the benefit of Parent and the Company in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any Person other than the parties to this Agreement any rights or remedies under this Agreement, including the right to rely upon the representations and warranties set forth in this Agreement, and the parties to this Agreement further agree that this Agreement may only be enforced against, and any Legal Action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against, the Persons expressly named as parties to this Agreement.

 

15.    Assignment; Successors.  Except in connection with Permitted Transfers, no party to this Agreement shall assign this Agreement (in whole or part) without the prior written consent of the other parties. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the parties and their respective permitted successors and assigns. Any attempted assignment in violation of the terms of this Section 15 shall be null and void, ab initio.

 

16.    Remedies.  All rights, powers and remedies provided under this Agreement or otherwise available in respect of this Agreement at law or in equity shall be cumulative and not alternative, and the exercise of any such right, power or remedy by any party to this Agreement shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such party.

 

17.    Enforcement.  The parties agree that irreparable damage, for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that the parties do not perform their obligations under the provisions of this Agreement in accordance with its specified terms or otherwise breach such provisions. The parties acknowledge and agree that (i) the parties shall be entitled to an injunction, specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, including each Stockholder’s obligations to vote its Covered Shares as provided in this Agreement, without proof of damages, this being in addition to any other remedy to which they are entitled under this Agreement, and (ii) the right of specific enforcement is an integral part of the transactions contemplated by this Agreement and without that right, none of the parties would have entered into this Agreement. Each party agrees that it will not oppose the granting of specific performance and other equitable relief on the basis that the other parties have an adequate remedy at Law or that an award of specific performance is not an appropriate remedy for any reason at Law or equity. The parties acknowledge and agree that any party seeking an injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Section 17 shall not be required to provide any bond or other security in connection with any such injunction.

 

18.    Capacity as a Stockholder.  Notwithstanding anything in this Agreement to the contrary, each Stockholder signs this Agreement solely in the Stockholder’s capacity as a stockholder of the Company, and not in any other capacity and this Agreement shall not limit or otherwise affect the actions or inactions of any Affiliate, Representative or designee of the Stockholder or any of its Affiliates in his or her capacity, if applicable, as an officer or director of any other Person.

 

7

 

 

19.    Miscellaneous. The provisions set forth in Sections 8.02 (Interpretation), 8.04 (Governing Law), 8.05 (Submission to Jurisdiction; Service), 8.06 (Waiver of Jury Trial), 8.12 (Severability), and 8.17 (Counterparts; Effectiveness), of the Merger Agreement, as in effect as of the date of this Agreement, are incorporated by reference into, and shall be deemed to apply to, this Agreement, mutatis mutandis.

 

 

 

 

[The remainder of this page is intentionally left blank.]

 

 

 

8

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			RHODIUM ENTERPRISES, INC.

				 
	 	 	 	 
	 	
			By:

				/s/ Chase Blackmon	 
	 	 	
			Name: Chase Blackmon

				 
	 	 	
			Title: Chief Executive Officer

				 

 

 

 

[Signature Page to Voting and Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			SILVERSUN TECHNOLOGIES, INC.

				 
	 	 	 	 
	 	
			By:

				/s/ Mark Meller	 
	 	 	
			Name: Mark Meller

				 
	 	 	
			Title: Chief Executive Officer

				 

 

 

 

[Signature Page to Voting and Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			STOCKHOLDER

				 
	 	 	 
	 	IMPERIUM INVESTMENTS HOLDINGS LLC	 
	 	 	 	 
	 	
			By:

				/s/ Cameron Blackmon	 
	 	
			Name:

				Cameron Blackmon	 
	 	Title:	Manager	 
	 	 	 	 
	 	
			Address:

			 

			Attn: Cameron Blackmon

			Email: cameronblackmon@RHDM.com

			Company Common Stock Held: 100 shares of Class B Common

				 

 

 

 

[Signature Page to Voting and Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			STOCKHOLDER

				 
	 	 	 	 
	 	
			By:

				/s/ Chase Blackmon	 
	 	
			Name:

				Chase Blackmon	 
	 	 	 	 
	 	 	 	 
	 	
			Address:

			 

			Email: chaseblackmon@RHDM.com

			Company Common Stock Held: 0

				 

 

 

 

 

[Signature Page to Voting and Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			STOCKHOLDER

				 
	 	 	 	 
	 	
			By:

				/s/ Cameron Blackmon	 
	 	
			Name:

				Chase Blackmon	 
	 	 	 	 
	 	 	 	 
	 	
			Address:

			 

			Email: cameronblackmon@RHDM.com

			Company Common Stock Held: 0

				 

 

 

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			STOCKHOLDER

				 
	 	 	 	 
	 	
			By:

				/s/ Nathan Nichols	 
	 	
			Name:

				Nathan Nichols	 
	 	 	 	 
	 	 	 	 
	 	
			Address:

			 

			Email: nathannichols@rhdm.com

			Company Common Stock Held: 0

				 

 

 

 

 

[Signature Page to Voting and Support Agreement]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed (where applicable, by their respective officers or other authorized Persons thereunto duly authorized) as of the date first written above.

 

	 	
			STOCKHOLDER

				 
	 	 	 	 
	 	
			By:

				/s/ Nicholas Cerasuolo	 
	 	
			Name:

				Nathan Nichols	 
	 	 	 	 
	 	 	 	 
	 	
			Address:

			 

			Email: nicholascerasuolo@RHDM.com

			Company Common Stock Held: 0

				 

 

 

 

[Signature Page to Voting and Support Agreement]EX-10.7

  
 

 
  
 1 

 

 EXHIBIT 10.7 

INDEMNIFICATION AGREEMENT 

between 
 [name]

 as the Officer 
 and 

NewAmsterdam Pharma Company N.V. 

as the Company 

  
 

 
  
 2 

 

 INDEMNIFICATION AGREEMENT 

THIS AGREEMENT IS MADE ON [DATE] BETWEEN 
  

	1.	 Mr[s]. [name], born in [place] on [date] (the
“Officer”). 

  

	2.	 NewAmsterdam Pharma Company N.V., a public company with limited liability, having its corporate seat in
Amsterdam (address: Gooimeer 2-35 1411 DC Naarden, trade register number: 86649051) (the “Company”). 

WHEREAS 
  

	A.	 The Officer has been appointed as [Non-]Executive Director.

  

	B.	 The Parties now wish to enter into this Agreement in order to lay down the terms applicable to the
indemnification arrangements between the Officer and the Company. 

 NOW HEREBY AGREE AS FOLLOWS 

 

	1	 DEFINITIONS AND INTERPRETATION 

 

	1.1	 Definitions 

  

	1.1.1	 In this Agreement the following definitions shall apply: 

 

			
	Agreement	  	This indemnification agreement.
		
	Article	  	An article of this Agreement.
		
	Board	  	The Company’s board of directors.
		
	Confidential Information	  	Information relating to the Company, its Subsidiaries and/or their respective businesses, directors, officers and employees, received by the Officer at any time (including prior to the date of this Agreement and after the
termination of this Agreement), by any means (including through discussions with any director, officer, employee or advisor of the Company or any of its Subsidiaries), except for
information:

  
 

 
  
 3 

 

			
		  	 a.  which is in the public domain, other than as a result of a breach by the
Officer (or by any party to whom information is disclosed by the Officer as permitted under this Agreement) of the obligations imposed by this Agreement or any other legal, contractual or fiduciary duty of confidentiality; or

 
 b.  of which the Officer is
able to demonstrate that it has lawfully become available to the Officer on a non-confidential basis from a source which was not prohibited from disclosing such information under any legal, contractual or
fiduciary duty of confidentiality.

		
	D&O Insurance	  	Directors and officers liability insurance.
		
	DCC	  	The Dutch Civil Code.
		
	Director	  	A member of the Board.
		
	Disinterested Director	  	Any Non-Executive Director who is not, and has not been, involved in a Proceeding in respect of which the Officer’s entitlement to indemnification and/or advancements should be
determined pursuant to Article 2.4.1 under a.
		
	[Executive Director]	  	[An executive Director.]
		
	Expenses	  	All reasonable and documented attorneys’ fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery
service fees and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding,
or responding to, or objecting to, a request to provide discovery in any Proceeding. Expenses also shall include expenses incurred in connection with any appeal resulting from any Proceeding and any federal, state, local or
foreign

  
 

 
  
 4 

 

			
		  	taxes imposed on the Officer as a result of the actual or deemed receipt of any payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond,
or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by the Officer or the amount of judgments or fines against the Officer.
		
	Group Company	  	An entity or partnership which is organisationally connected with the Company in an economic unit within the meaning of Section 2:24b DCC.
		
	Independent Counsel	  	 An attorney or a firm of attorneys which:
  

a.  is experienced in matters of corporate law in the appropriate jurisdiction(s);

 
 b.  during a period of one
year prior to being requested to determine the Officer’s entitlement to indemnification and/or advancements pursuant to Article 2.4.1 under b., has not represented any party involved in a Proceeding in a manner which is material to either
Party; and
  

c.   under the applicable standards of professional conduct then prevailing, would not have a
conflict of interests in representing either Party in determining the Officer’s entitlement to indemnification and/or advancements pursuant to Article 2.4.1 under b.

		
	[Non-Executive Director]	  	[A non-executive Director.]
		
	Party	  	A party to this Agreement.
		
	Proceeding	  	Any threatened, pending or completed suit, claim, action or legal proceedings of a civil, criminal, administrative, investigative or other nature, formal or informal, in which the Officer is, or becomes, involved.
		
	Stock Exchange	  	Any of the following (including, for the avoidance of doubt, the Nasdaq Stock Market):

  
 

 
  
 5 

 

			
		  	 a.  a regulated market or multilateral trading facility as defined in
Section 1:1 of the Dutch Financial Supervision Act; or
  

b.  a system comparable with a regulated market or multilateral trading facility as referred to
under a. above, operating in a state which is not a Member State of the European Union or the European Economic Area.

		
	Subsidiary	  	A subsidiary of the Company within the meaning of Section 2:24a DCC.

  

	1.2	 Interpretation 

 

	1.2.1	 References to statutory provisions are to those provisions as they are in force from time to time.

  

	1.2.2	 Terms that are defined in the singular have a corresponding meaning in the plural. 

 

	1.2.3	 No provision of this Agreement shall be interpreted adversely against a Party solely because that Party was
responsible for drafting that particular provision. 

  

	1.2.4	 Although this Agreement has been drafted in the English language, this Agreement pertains to Dutch legal
concepts. Any consequence of the use of English words and expressions in this Agreement under any law other than Dutch law shall be disregarded. 

  

	1.2.5	 The word “including” is used to indicate that the matters listed are not a complete enumeration of
all matters covered. 

  

	1.2.6	 The titles and headings in this Agreement are for construction purposes as well as for reference. No Party may
derive any rights from such titles and headings. 

  

	2	 INDEMNIFICATION AND INSURANCE 

 

	2.1	 Entitlement to indemnification 

 

	2.1.1	 The Company shall indemnify the Officer and hold the Officer harmless against: 

 

	 	a.	 any financial losses or damages incurred by the Officer; and 

  
 

 
  
 6 

 

	 	b.	 any Expense reasonably paid or incurred by the Officer in connection with any Proceeding,

 in each case to the extent this relates to the Officer’s current (or former) position as [Non-] Executive Director or to the Officer’s current or former position with a Group Company and to the extent permitted by applicable law. 

 

	2.1.2	 The right to indemnification conferred in Article 2.1.1 shall continue as to the Officer who has ceased to hold
office as [Non-]Executive Director and shall inure to the benefit of the Officer’s heirs, executors and administrators, subject always to Article 3.9. 

 

	2.2	 Advancements 

  

	2.2.1	 The Company shall promptly advance all reasonable and necessary Expenses incurred by the Officer in connection
with any Proceeding to the extent that the Company reasonably believes that the Officer is entitled to indemnification pursuant to Articles 2.1.1 and 2.3.1 in connection with such Proceeding, subject to the Officer submitting an itemised advance
request to the Company. 

  

	2.2.2	 To the extent that the Company has provided advancements pursuant to Article 2.2.1 in connection with a
Proceeding in respect of which the Officer is not entitled to indemnification pursuant to Articles 2.1.1 and 2.3.1, such advancements shall promptly be reimbursed by the Officer. 

 

	2.3	 Limitations 

  

	2.3.1	 No indemnification shall be given to the Officer: 

 

	 	a.	 if a competent court or arbitral tribunal has established that the acts or omissions of the Officer that led to
the financial losses, damages, Expenses or Proceeding are of an unlawful nature (including acts or omissions which are considered to constitute malice, gross negligence, intentional recklessness and/or serious culpability attributable to the
Officer) and the Officer does not have, or no longer has, the possibility to appeal such decision; 

  

	 	b.	 to the extent that the Officer’s financial losses, damages and Expenses are covered under insurance
(including any applicable D&O Insurance) and the relevant insurer has settled, or has provided reimbursement for, these financial losses, damages and Expenses (or has irrevocably undertaken to do so); 

 

	 	c.	 in relation to proceedings brought by the Officer against the Company, except for proceedings brought to
enforce indemnification to which the Officer is entitled pursuant to this Agreement, the Company’s articles of association or any D&O Insurance taken out by the Company for the benefit of the Officer; or 

  
 

 
  
 7 

 

	 	d.	 for any financial losses, damages or Expenses incurred in connection with a settlement of any Proceeding
effected without the Company’s prior consent. 

  

	2.3.2	 Any provision herein to the contrary notwithstanding, the Company shall not be obligated to indemnify or
advance Expenses to the Officer with respect to proceedings or claims initiated or brought by the Officer against the Company or its agents and not by way of defense, except (i) with respect to proceedings brought to establish or enforce a
right to indemnification or advancement under this Agreement or under any other agreement, provision in the Company’s articles of association or applicable law, or (ii) with respect to any other proceeding initiated by the Officer that is
either approved by the Board or the Officer’s participation is required by applicable law. However, indemnification or advancement of Expenses may be provided by the Company in specific cases if the Board determines it to be appropriate.

  

	2.4	 Determination of entitlement to indemnification and advancements 

 

	2.4.1	 If the Officer wishes to claim indemnification and/or advancements pursuant to Articles 2.1 and 2.2, the
Officer shall submit a request to that effect to the Company. Upon receipt of such request, the Officer’s entitlement to indemnification and/or advancements pursuant to Articles 2.1 and 2.2 shall be determined by any of the following (at the
election of the Company): 

  

	 	a.	 so long as there are Disinterested Directors, either by majority vote of all Disinterested Directors or by
majority vote of a committee composed exclusively of Disinterested Directors, provided that such committee is established by majority vote of all Disinterested Directors; or 

 

	 	b.	 Independent Counsel in a written opinion delivered to each Party. 

 

	2.4.2	 If the Company decides to request Independent Counsel to make the determination referred to in Article 2.4.1,
the Company shall notify the Officer of the identity of the Independent Counsel selected by it. The Officer may, within one week, notify the Company of its objection to the Independent Counsel selected by the Company, but only on the grounds that
the relevant attorney or firm of attorneys does not meet the criteria of the definition of “Independent Counsel”. In case of such objection being timely made and deemed well-founded by the Company, the Company shall select a different
Independent Counsel and the previous two sentences apply mutatis mutandis in respect of such selection. The Company shall pay all fees and other expenses associated with the retention and services of Independent Counsel to make the determination
referred to in Article 2.4.1. 

  
 

 
  
 8 

 

	2.4.3	 The Company shall exert all reasonable efforts to cause any determination required under Article 2.4.1 to be
made as promptly as practicable after the Officer has submitted its initial request for indemnification and/or advancements pursuant to Articles 2.1 and 2.2 and the Officer shall fully cooperate with the person(s) making such determination.

  

	2.5	 Proceedings 

  

	2.5.1	 The Officer shall promptly notify the Company upon receipt of any complaint, demand letter, writ of summons or
other document relating to any Proceeding which may result in the indemnification or advancement of Expenses hereunder. The failure to so notify the Company shall not relieve the Company of any obligation which it may have to the Officer under this
Agreement or otherwise unless and only to the extent that such failure or delay materially prejudices the Company. 

  

	2.5.2	 The Officer shall allow the Company to participate in any Proceeding and to assume the defence thereof in such
manner as the Company deems appropriate, with counsel selected by the Company and reasonably satisfactory to the Officer, provided that: 

  

	 	a.	 the Company must conduct any such defence in good faith and in a diligent manner; and 

 

	 	b.	 the Company shall not, without the Officer’s prior consent, allow or condone any judgment or award against
the Officer nor enter into any settlement or compromise pursuant to which non-monetary obligations or penalties (including incarceration) would be imposed on the Officer and/or monetary obligations would be
imposed on the Officer which would not be indemnified in full pursuant to Articles 2.1.1 and 2.3.1. 

  

	2.6	 D&O Insurance 

 

	2.6.1	 The Company may take out and maintain D&O Insurance for the benefit of the Officer for as long as the
Officer serves as [Non-]Executive Director, subject to the acceptance of the Officer under the conditions by the insurer concerned. 

 

	2.6.2	 The premiums payable for D&O Insurance covering the Officer as an insured shall be borne by the Company.

  
 

 
  
 9 

 

	3	 MISCELLANEOUS PROVISIONS 

 

	3.1	 Confidentiality and disclosure 

 

	3.1.1	 Subject to Articles 3.1.2 through 3.1.5, the Officer shall treat and safeguard as private and confidential all
Confidential Information at all times and shall keep any copies thereof secure in such way so as to prevent unauthorised access by any third party. 

  

	3.1.2	 The Officer shall not disclose any Confidential Information, unless: 

 

	 	a.	 this is required under applicable law, Stock Exchange requirements and/or by any competent authority; or

  

	 	b.	 it concerns a disclosure to the Officer’s professional advisors, subject to a duty of confidentiality and
only to the extent necessary for any lawful purpose. 

  

	3.1.3	 Any disclosure of Confidential Information by the Officer under Article 3.1.2 shall be delayed until the
Company has been consulted about the timing and content of such disclosure, to the extent that such a delay would be legally permissible. 

  

	3.1.4	 The Officer shall, at the Company’s first request and in any event upon the termination of this Agreement,
promptly return or destroy all Confidential Information which the Officer has at [his/her] disposal, except to the extent that the Officer is required by applicable law to retain such Confidential Information. 

 

	3.1.5	 All Confidential Information shall remain the exclusive property of the Company and/or its Subsidiaries, as the
case may be. No right or licence is granted pursuant to this Agreement in relation to any Confidential Information. 

  

	3.2	 Notices 

  

	3.2.1	 All notices given under this Agreement shall be given or made by electronic means of communication or in
writing and, in the latter case, shall be sent by courier service or by registered mail (with a copy of such notice or request being sent in advance by electronic means of communication). 

 

	3.2.2	 All notices given under this Agreement to a Party which are sent by courier or by registered mail shall be
sent: 

  

	 	a.	 if to the Officer, to the address as on file with the Company at that time; and 

 

	 	b.	 if to the Company, to address as registered with the Dutch trade registry at that time, for the attention of
the Board. 

  
 

 
  
 10 

 

	3.2.3	 All notices given under this Agreement to a Party by electronic means of communication shall be sent:

  

	 	a.	 if to the Officer, to: [e-mail address]

  

	 	b.	 if to the Company, to: [e-mail address]

  

	3.3	 Entire agreement 

 

	3.3.1	 This Agreement replaces and supersedes any existing indemnification agreement between the Parties, including
any indemnification arrangements agreed between the Parties as part of a service, employment or other agreement, provided, however, that this Agreement is a supplement to and in furtherance of other rights which the Officer may be entitled to under
any provision of applicable law or the Company’s articles of association, and shall not be deemed a substitute therefor, and does not diminish or abrogate any rights of Officer’s thereunder. 

 

	3.4	 No implied waiver 

 

	3.4.1	 Nothing shall be construed as a waiver under this Agreement unless a document to that effect has been signed by
the Parties or a notice to that effect has been given. 

  

	3.4.2	 The failure of a Party to exercise or enforce any right under this Agreement shall not constitute a waiver of
the right to exercise or enforce such right in the future. 

  

	3.5	 Amendment 

  

	3.5.1	 No amendment to this Agreement shall have any force or effect unless it is in writing and signed by both
Parties. 

  

	3.6	 Invalidity 

  

	3.6.1	 In the event that a provision of this Agreement is null and void or unenforceable (either in whole or in part):

  

	 	a.	 the remainder of this Agreement shall continue to be effective to the extent that, given the substance and
purpose of this Agreement, such remainder is not inextricably related to the null and void or unenforceable provision; and 

  

	 	b.	 the Parties shall make every effort to reach agreement on a new provision which differs as little as possible
from the null and void or unenforceable provision, taking into account the substance and purpose of this Agreement. 

  
 

 
  
 11 

 

	3.7	 No rescission or nullification 

 

	3.7.1	 To the extent permitted by law, the Parties waive their rights to rescind or nullify or to demand the
rescission, nullification or amendment of this Agreement, in whole or in part, on any grounds whatsoever. 

  

	3.8	 No transfer, assignment or encumbrance 

 

	3.8.1	 No Party may transfer, assign or encumber its contractual relationship, any of its rights or any of its
obligations under this Agreement. 

  

	3.9	 Term and termination 

 

	3.9.1	 Subject to Article 3.9.3, this Agreement shall remain in full force for the duration of the Officer’s term
of office as [Non-]Executive Director and shall terminate, without prior notice being required, at the moment when the Officer ceases to be a [Non-]Executive Director.

  

	3.9.2	 For purposes of Article 3.9.1, the Officer’s term of office shall not be considered to have expired or
interrupted if the Officer is reappointed as [Non-]Executive Director for consecutive terms. 

  

	3.9.3	 In case of a termination of this Agreement, the Officer’s right to indemnification under Article 2 shall
terminate at (and, exclusively for that purpose, the relevant provisions of this Agreement shall survive until) the later of the following moments: 

  

	 	a.	 the expiration of the statute of limitations applicable to any claim that could be asserted against the Officer
with respect to which the Officer would be entitled to indemnification under this Agreement; 

  

	 	b.	 ten years after the date that the Officer has ceased to serve as a
[Non-]Executive Director; or 

  

	 	c.	 if, at the later of the dates referred to in paragraphs a. and b. above, there would be an actual or pending
Proceeding in respect of which the Officer would be entitled to indemnification under this Agreement or there is an actual or pending Proceeding in connection with this Agreement, one year after the competent court or arbitral tribunal has finally
adjudicated such Proceeding, without possibility for appeal. 

  

	3.10	 Securities Act Liabilities. 

 

	3.10.1	 Any provision herein to the contrary notwithstanding, the Company shall not be obligated pursuant to the terms
of this Agreement to indemnify the Officer if such indemnification 

  
 

 
  
 12 

 

	 	would be a violation of any undertaking appearing in and required by the rules and regulations promulgated under the Securities Act of 1933, as amended (the “Act”) or in any registration statement filed with
the Securities Exchange Commission under the Act. The Officer acknowledges that paragraph (h) of Item 512 of Regulation S-K currently generally requires the Company to undertake in connection with any
registration statement filed under the Act to submit the issue of the enforceability of the Officer’s rights under this Agreement in connection with any liability under the Act on public policy grounds to a court of appropriate jurisdiction and
to be governed by any final adjudication of such issue. The Officer specifically agrees that any such undertaking shall supersede the provisions of this Agreement and to be bound by any such undertaking. 

 

	3.11	 Subrogation 

  

	3.11.1	 In the event of any payment pursuant to Section 2.1 and Section 2.2 under this Agreement, the Company
shall be subrogated to the extent of such payment to all of the rights of contribution or recovery of the Officer against other persons, and the Officer shall take, at the request of the Company, all reasonable action necessary to secure such
rights, including the execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. 

  

	4	 GOVERNING LAW AND JURISDICTION 

 

	4.1	 Governing law 

 

	4.1.1	 This Agreement shall be governed by and construed in accordance with the laws of the Netherlands.

  

	4.2	 Jurisdiction 

  

	4.2.1	 The Parties agree that any dispute in connection with this Agreement or any agreement resulting therefrom shall
be submitted to the exclusive jurisdiction of the competent court in Amsterdam, the Netherlands. 

 (signature page
follows) 

  
 

 
  
 13 

 

	
	Signature page to the indemnification agreement
	
	  

	[name Officer]
	
	  

	NewAmsterdam Pharma Company N.V.
	 Name    :

Title      :

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]